Hepatitis B reactivation in chronic myeloid leukemia patients receiving tyrosine kinase inhibitor

doi:10.3748/wjg.v19.i8.1318

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 8

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6240)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series.

Item

Count

PDF

497

HTML

3554

Figures (1-1)

126

Sum=4177

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

986

Download

1077

Sum=2063

Feb 28, 2013 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (56)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Gastroenterol. Feb 28, 2013; 19(8): 1318-1321
Published online Feb 28, 2013. doi: 10.3748/wjg.v19.i8.1318

Full Size Figure Download Figure

Figure 1 Clinical course of cases. A: Case 1, showing alanine transaminase (ALT) and Bcr-Abl/Abl^IS ratio over time; B: Case 2, showing ALT and Bcr-Abl/Abl^IS ratio over time; C: Case 3, showing ALT and Bcr-Abl/Abl^IS ratio over time. IM: Imatinib mesylate; IS: International scale.

Citation: Lai GM, Yan SL, Chang CS, Tsai CY. Hepatitis B reactivation in chronic myeloid leukemia patients receiving tyrosine kinase inhibitor. World J Gastroenterol 2013; 19(8): 1318-1321
URL: https://www.wjgnet.com/1007-9327/full/v19/i8/1318.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i8.1318